Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction. (Q53959586)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 1998

Language	Label	Description	Also known as
English	Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.	scientific article published in January 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Rik C Schoemaker

7

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

author name string

van Griensven JM

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Koster RW

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Burggraaf J

3

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Huisman LG

4

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Kluft C

5

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Kroon R

6

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Cohen AF

8

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

63

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

39-47

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

21 January 2018

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

In vivo metabolism of human tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

The pharmacokinetics of recombinant double-chain t-PA (duteplase): effects of bolus injection, infusions, and administration by weight in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Lidocaine kinetics predicted by indocyanine green clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Effect of hypotension on liver blood flow and lidocaine disposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Estimation of hepatic blood flow with indocyanine green

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Pharmacokinetics of biliary excretion in man. VI. Indocyanine green

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

A randomized dose-ranging study of rt-PA in acute myocardial infarction. Effects on coronary patency and fibrinolytic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

High-pressure liquid chromatographic analysis of indocyanine green.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Do Beta Blockers Differ in Their Effects on Hepatic Microsomal Enzymes and Liver Blood Flow?

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990119-9

7 January 2021

Identifiers

10.1016/S0009-9236(98)90119-9

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

release_bwkoi3qbxvhf7oxaq6e72wfx3i

1 reference

https://api.fatcat.wiki/v0/release/bwkoi3qbxvhf7oxaq6e72wfx3i

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9465840

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53959586&oldid=2143553877"